Doriane Mathé
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Immune cells in cancer 2
- Immunotherapy and Immune Responses 2
- Mast cells and histamine 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Charles Dumontet (13 shared papers)Eva‐Laure Matera (8 shared papers)Kamel Chettab (7 shared papers)Minh Ngoc Duong (2 shared papers)Sandrine Valsesia‐Wittmann (2 shared papers)Béatrice Clemenceau (2 shared papers)Lars Petter Jordheim (4 shared papers)Emeline Cros‐Perrial (3 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Bioconjugate Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)mAbs (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceSwitzerland
In The Last Decade
Doriane Mathé
13 papers receiving 334 citations
Peers
Comparison fields: 5 of 48
- Oncology 147
- Cancer Research 41
- Immunology 53
- Genetics 19
- Biotechnology 11
Countries citing papers authored by Doriane Mathé
This map shows the geographic impact of Doriane Mathé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doriane Mathé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doriane Mathé more than expected).
Fields of papers citing papers by Doriane Mathé
This network shows the impact of papers produced by Doriane Mathé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doriane Mathé. The network helps show where Doriane Mathé may publish in the future.
Co-authors
The 25 scholars most cited alongside Doriane Mathé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 108 | |
| 2 | 2015 | 96 | |
| 3 | 2022 | 27 | |
| 4 | 2014 | 25 | |
| 5 | 2015 | 20 | |
| 6 | 2017 | 15 | |
| 7 | 2016 | 11 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2018 | 5 | |
| 11 | 2017 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2017 | 3 |
About Doriane Mathé
Doriane Mathé is a scholar working on Immunology, Oncology, Biomaterials, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 13 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunotherapy and Immune Responses (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Ultrasound and Hyperthermia Applications (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Oncology (147 citations), Cancer Research (41 citations), Immunology (53 citations), Genetics (19 citations) and Biotechnology (11 citations). Doriane Mathé has collaborated with scholars based in France and Switzerland. Frequent co-authors include Charles Dumontet, Eva‐Laure Matera, Kamel Chettab, Minh Ngoc Duong, Sandrine Valsesia‐Wittmann, Béatrice Clemenceau, Lars Petter Jordheim, Emeline Cros‐Perrial, Cyril Lafon and Jean‐Louis Mestas. Their work appears in journals such as Frontiers in Immunology, Bioconjugate Chemistry, Molecular Cancer Therapeutics, mAbs and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.